skip to the content

Clinical Trials

ADVENT Trial

Randomized Double-Blind, Parallel-Group, Placebo-Controlled, Two-stage Study to Assess the Efficacy and Safety of Crofelemer 125mg, 250 mg, and 500 mg Orally Twice Daily for the Treatment of HIV- Associated Diarrhea (ADVENT Trial)

Protocol ID

07-02-136

Protocol Description

Diarrhea is a common and concerning problem for many people with HIV. Besides being uncomfortable, it can have negative effects on a patient's lifestyle, ability to work and response to therapy. Current medications used to treat diarrhea may not be effective and may have side effects.

This study involves taking an experimental drug called Crofelemer, for the possible treatment of HIV-associated diarrhea. The purpose of this study is to test the efficacy and safety of crofelemer in treating subjects with HIV-associated diarrhea.

Eligibility Criteria

Patients with HIV-associated diarrhea

Primary Investigator(s)

  • Joseph McGowan, MD

Contact Information

Loretta Sullivan
(516) 562-4280
lsulliva@nshs.edu

Last Update

February 1, 2012
top
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Infectious Diseases:
top
top